Wells Fargo’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-797,807
| Closed | -$77.8M | – | 6367 |
|
|
2015
Q1 | $77.8M | Buy |
797,807
+363,265
| +84% | +$35.4M | 0.03% | 596 |
|
|
2014
Q4 | $40.3M | Sell |
434,542
-143,718
| -25% | -$13.3M | 0.02% | 880 |
|
|
2014
Q3 | $39.8M | Buy |
578,260
+565,457
| +4,417% | +$38.9M | 0.02% | 853 |
|
|
2014
Q2 | $1.34M | Sell |
12,803
-100,780
| -89% | -$10.6M | ﹤0.01% | 3267 |
|
|
2014
Q1 | $9.42M | Buy |
113,583
+95,362
| +523% | +$7.91M | ﹤0.01% | 1834 |
|
|
2013
Q4 | $1.18M | Sell |
18,221
-25,683
| -58% | -$1.66M | ﹤0.01% | 3289 |
|
|
2013
Q3 | $2.78M | Sell |
43,904
-165,838
| -79% | -$10.5M | ﹤0.01% | 2634 |
|
|
2013
Q2 | $8.8M | Buy |
+209,742
| New | +$8.8M | ﹤0.01% | 1675 |
|